Company / Net Debt per Share
NeoGenomics Laboratories, Inc. Net Debt per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
$1.42
FY2025
5-year range
$1.37 / $1.56
FY2021-FY2025
Trend
+3.5%
vs FY2024
Sector context
#68 of 98
Health Care
What the data says
At $1.42, NeoGenomics Laboratories, Inc.'s net debt per share ranks #31 of 98 in the Health Care sector. Net Debt per Share has fluctuated over the past 6 years, ranging from $1.00 in FY2018 to $1.56 in FY2023.
Based on SEC 10-K filings.
1.42 in FY2025.
Improved from $1.56 to $1.42 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#31 of 98 in Health CareTop 31% of 98This company $1.42 Sector average $7.39
▼
-80.8% below sector average
Key checks
Key Insights
- In FY2025, net debt per share increased 3.5% year-over-year.
- Ranks #68 out of 98 companies in the Health Care sector.
- Peak net debt per share was recorded in FY2023.
- Lowest net debt per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.42 | +3.5% |
| FY2024 | $1.37 | -11.9% |
| FY2023 | $1.56 | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | $1.00 | -5.9% |
| FY2017 | $1.07 | -5.2% |
| FY2016 | $1.13 | +114.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026